PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Quarter Est. Return
1 Year Est. Return
+121.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$62.4M
AUM Growth
-$14.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$12.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$170M
$49.5M 79.24%
569,889
LYRA icon
2
Lyra Therapeutics
LYRA
$11.3M
$8.84M 14.16%
22,017
XFOR icon
3
X4 Pharmaceuticals
XFOR
$66.7M
$2.02M 3.24%
10,383
ATYR
4
aTyr Pharma
ATYR
$99.9M
$637K 1.02%
130,572
DARE icon
5
Dare Bioscience
DARE
$27.4M
$617K 0.99%
27,187
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$462K 0.74%
197,345
PULM icon
7
Pulmatrix
PULM
$17.6M
$374K 0.6%
17,972
RNAC icon
8
Cartesian Therapeutics
RNAC
$234M
– –
-92,449